ChronoScale Holdings Corporation filed a Form 8-K on September 16, 2026, disclosing that its subsidiaries entered into a First Amendment to a Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC, extending the maturity date of a $2.0 million term loan.
Key Highlights
- Amendment effective date: September 12, 2026
- Term loan principal outstanding: $2.0 million as of the date of the First Amendment
- Extended maturity date: The maturity date under clause (i) of the original agreement was extended to November 12, 2026
- Permitted Disposition added: The First Amendment provides that the sale of the Guarantor, Ekso Bionics, Inc., on specified terms shall constitute a Permitted Disposition
- Original equity trigger unchanged: The alternative maturity condition requiring $2.4 million in net proceeds from new equity investors remains in effect
- All other terms: According to the filing, "all other material terms of the Agreement remain unchanged"
ChronoScale Intermediate LLC Extends Term Loan with B. Riley Commercial Capital
According to the filing, ChronoScale Intermediate, LLC (formerly known as Ekso Bionics Holdings, Inc. and ChronoScale Corporation), as borrower, and Ekso Bionics, Inc., as guarantor, entered into the First Amendment to the Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC as lender. The filing identifies both entities as wholly owned subsidiaries of ChronoScale Holdings Corporation (NASDAQ:CHRN), a Nevada corporation.
The original Secured Promissory Note and Security Agreement was dated September 12, 2025, and provided the borrower with a term loan in an aggregate principal amount of up to $2.0 million. As the filing disclosed, the agreement originally set the maturity date as the earlier of the twelve-month anniversary of the agreement or the receipt of $2.4 million in net proceeds from the sale of equity interests to new equity investors. As of the First Amendment's effective date, the full $2.0 million principal amount remained outstanding.
The First Amendment, according to the filing, makes two principal changes: it extends the twelve-month anniversary maturity date to November 12, 2026, and it provides that a sale of the guarantor, Ekso Bionics, Inc., on the terms and conditions set forth in the First Amendment shall constitute a Permitted Disposition as defined in that document. The filing notes that all other material terms of the original agreement remain unchanged. The full text of the First Amendment was attached as Exhibit 10.1 to the current report.
What Was Disclosed
ChronoScale Holdings reported that its subsidiaries amended an existing $2.0 million term loan agreement with B. Riley Commercial Capital, LLC, extending the maturity date to November 12, 2026, and designating a potential sale of guarantor Ekso Bionics, Inc. as a Permitted Disposition.



Please wait processing your request...